Form 4: Precigen CLO Lehr Boosts Stake with RSU Conversion
Insider Transaction Report
Precigen's Chief Legal Officer, Donald P. Lehr, increased his direct beneficial ownership of common stock by 40,443 shares following the vesting and conversion of Restricted Stock Units.
Summary
- Donald P. Lehr, Chief Legal Officer of Precigen, Inc. (PGEN), acquired 40,443 shares of common stock on March 18, 2026.
- This acquisition resulted from the immediate vesting and conversion of 40,443 Restricted Stock Units (RSUs).
- Following the transaction, Lehr's direct beneficial ownership of Precigen common stock stands at 722,092 shares.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as increased insider ownership generally indicates management's confidence in the company's future, though it's a standard compensation event.
Positives
- Increased insider ownership by a key executive, which can signal confidence in the company's future prospects.
- The immediate vesting of RSUs indicates a direct conversion to common stock, strengthening the executive's alignment with shareholder interests.
Industry Context
StockSavvy.ai notes that insider stock acquisitions, particularly through equity compensation mechanisms like RSU conversions, are a routine part of executive compensation in the biotechnology and pharmaceutical sectors, aligning management incentives with long-term shareholder value.
Comparison to Industry Standards
- This type of equity compensation and subsequent conversion is standard practice across publicly traded companies, including peers in the biotech industry such as Moderna (MRNA) or BioNTech (BNTX), where executive compensation often includes significant equity components to incentivize performance and retention.
Stakeholder Impact
- Shareholders: Increased alignment of executive interests with shareholders due to higher direct stock ownership.
- Employees: Standard equity compensation practices can positively influence employee retention and motivation.
Key Dates
| Date | Description |
|---|---|
| 03/18/2026 | Date of earliest transaction (acquisition of common stock and RSU vesting/conversion). |
| 03/20/2026 | Signature date of the reporting person. |
Recommendation
holdThe filing reports a routine insider transaction where the Chief Legal Officer converted vested Restricted Stock Units into common stock, increasing his beneficial ownership. While this signals management confidence, it is a standard compensation event and does not provide new fundamental information to warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals.
Keywords
Precigen, PGEN, Donald P. Lehr, Chief Legal Officer, Insider Trading, Form 4, Restricted Stock Units, RSU conversion, Stock Ownership, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.